Clinical Trial Update: Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial comparing TDM1 with lapatinib and Abraxane versus trastuzumab with pertuzumab and paclitaxel in breast cancer; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Lapatinib (Lapatinib)
• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• T-DM1 (trastuzumab emtansine) (trastuzumab emtansine)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-09-22